Akebia Therapeutics Inc (AKBA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Akebia Therapeutics Inc-Aktie (AKBA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.95% 57.62	58.77	62.47	57.34	46.50
Cost Of Revenue	33.59% 12.54	9.383	9.919	7.625	20.36
Gross Profit	8.70% 45.09	49.38	52.55	49.71	26.13
Operating Expenses	19.38% 53.64	44.93	38.46	36.20	40.44
Benefits Costs and Expenses	19.52% 68.86	57.61	62.23	51.22	69.30
Costs And Expenses	19.52% 68.86	57.61	62.23	51.22	69.30
Operating Income/Loss	292.25% -8.553	4.449	14.09	13.51	-14.31
Income/Loss From Continuing Operations Before Tax	1,073% -11.23	1.155	0.247	6.112	-22.80
Income Tax Expense/Benefit	64.07% 1.009	0.615	-	-	-
Income/Loss From Continuing Operations After Tax	2,367% -12.24	0.54	0.247	6.112	-22.80
Net Income/Loss	2,367% -12.24	0.54	0.247	6.112	-22.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.95% 2.7673	264.79	262.57	235.50	2.603
Diluted Average Shares	102.01% -5.5232	274.37	271.10	241.60	2.603
Basic Earnings Per Share	-0.05	-	-	0.03	-0.11
Diluted Earnings Per Share	-0.05	-	-	0.03	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%